---
title: AML/T cell interactomics uncover correlates of patient outcomes and the key
  role of ICAM1 in T cell killing of AML
date: '2024-05-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38724673/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240510182053&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: T cells are important for the control of acute myeloid leukemia (AML),
  a common and often deadly malignancy. We observed that some AML patient samples
  are resistant to killing by human-engineered cytotoxic CD4^(+) T cells. Single-cell
  RNA-seq of primary AML samples and CD4^(+) T cells before and after their interaction
  uncovered transcriptional programs that correlate with AML sensitivity or resistance
  to CD4^(+) T cell killing. Resistance-associated AML programs were enriched in AML
  ...
disable_comments: true
---
T cells are important for the control of acute myeloid leukemia (AML), a common and often deadly malignancy. We observed that some AML patient samples are resistant to killing by human-engineered cytotoxic CD4^(+) T cells. Single-cell RNA-seq of primary AML samples and CD4^(+) T cells before and after their interaction uncovered transcriptional programs that correlate with AML sensitivity or resistance to CD4^(+) T cell killing. Resistance-associated AML programs were enriched in AML ...